Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell cycle regulatory proteins are a group of molecules that control the progression and fidelity of the cell cycle, ensuring proper cell division and response to internal and external signals. These proteins include both positive regulators (which promote cell cycle progression) and negative regulators (which halt or slow down the cycle in response to problems such as DNA damage. Key families include cyclins, cyclin-dependent kinases (Cdks), Cdk inhibitors (CKIs), Retinoblastoma protein (Rb), and p53. These proteins function through protein complex formation/dissociation, phosphorylation/dephosphorylation events, and targeted proteolysis via ubiquitination pathways to ensure orderly transitions between cell cycle phases and enforce checkpoints. Dysregulation is a hallmark feature in cancer development.
Various, including kinase inhibition, proteolysis induction, and transcriptional modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Cycle Regulatory Proteins.